Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.75 | €24.13 | 63.670% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €50.52 | €55.00 | 8.868% |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.68 | €4.62 | 580.560% |
| Bruker Corp. | 7 | 1 | 1 | 0 | €71.20 | €84.02 | 18.011% |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | €6.20 | €8.27 | 33.432% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.49 | - | - |
| Boston Scientific | 48 | 0 | 11 | 0 | €70.00 | €73.40 | 4.854% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €94.84 | - | - |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €77.00 | €75.94 | -1.382% |
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | €264.80 | €445.58 | 68.272% |
| Biolife Solutions Inc | 1 | 0 | 1 | 0 | €19.30 | - | - |
| Biogen Inc. | 49 | 1 | 8 | 1 | €201.00 | €293.57 | 46.056% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.66 | €11.05 | 95.318% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €69.34 | €100.00 | 44.217% |
| Axonics Modulation Technologies Inc | 8 | 0 | 0 | 0 | €62.00 | €66.36 | 7.032% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €8.10 | €8.75 | 8.025% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Atossa Genetics Inc | 7 | 1 | 2 | 0 | €1.35 | €3.74 | 177.831% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €22.94 | €52.03 | 126.787% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.22 | €11.00 | 76.906% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €37.43 | €70.00 | 87.016% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €23.40 | €28.29 | 20.900% |
| AnaptysBio Inc | 8 | 1 | 3 | 0 | €22.80 | €45.21 | 98.289% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €5.95 | €10.00 | 68.067% |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | €8.75 | €17.78 | 103.191% |